Gene expression profiling and its utility in prediction of local relapse after breast-conserving therapy in early breast cancer.
Local relapse (LR) after breast-conserving therapy (BCT) is not accurately predicted by histological/clinical factors. Gene expression profiling was used here to discover LR-associated transcriptional alterations. Gene expression profiling was carried out of 81 early breast carcinomas obtained from 30 patients who developed a LR (LR(+)) after BCT and 51 who did not (LR(-)). LR(+) and LR(-) samples were matched for known LR risk features. LR was not associated with a given molecular subtype. Supervised analysis identified a 212-gene signature, which was not validated in independent tumors. No gene set or biological pathway was differentially expressed between LR(+) and LR(-) groups. Twelve published prognostic expression signatures failed to distinguish these groups of carcinomas. The gene expression profiles of 9 cases of LR and the corresponding primary tumors were very similar despite the delivery of radiotherapy. In this series, the onset of LR was not predicted by gene expression alterations.